DOI QR코드

DOI QR Code

A Case of Primary Autoimmune Myelofibrosis

원발성 자가면역 골수섬유증 1예

  • Lim, Yeongmin (Department of Internal Medicine, School of Medicine, CHA University) ;
  • Park, Chi Young (Department of Internal Medicine, School of Medicine, CHA University) ;
  • Hong, Won Jung (Department of Internal Medicine, School of Medicine, CHA University) ;
  • Kim, Gwangil (Department of Pathology, School of Medicine, CHA University) ;
  • Chong, Soyoung (Department of Internal Medicine, School of Medicine, CHA University) ;
  • Oh, Doyeun (Department of Internal Medicine, School of Medicine, CHA University)
  • 임영민 (차의과학대학교 내과학교실) ;
  • 박치영 (차의과학대학교 내과학교실) ;
  • 홍원정 (차의과학대학교 내과학교실) ;
  • 김광일 (차의과학대학교 병리학교실) ;
  • 정소영 (차의과학대학교 내과학교실) ;
  • 오도연 (차의과학대학교 내과학교실)
  • Received : 2013.04.09
  • Accepted : 2013.09.01
  • Published : 2014.05.01

Abstract

Primary autoimmune myelofibrosis, the development of which is not preceded by a well-defined autoimmune disease, has recently been defined as a distinct clinicopathologic syndrome. We report herein a case of a 68-year-old woman who was diagnosed with primary autoimmune myelofibrosis and present a review of the literature. The patient manifested peripheral pancytopenia, was positive for autoantibodies, and developed myelofibrosis with no preceding autoimmune or hematologic disorders. Her condition was dramatically improved after administration of prednisolone.

혈구 감소 정도에 비해 경도의 골수섬유증을 동반한 원발성 자가면역 골수섬유증 1예로 스테로이드 및 소량의 면역억제제 사용으로 양호한 혈액학적 소견을 유지하고 골수섬유증의 호전을 보였다. 이 원발성 자가면역 골수섬유증은 선행하는 자가면역 질환이 없고 범혈구 감소증 및 자가면역항체 양성, 골수섬유화증의 증거가 있을 때 감별진단의 하나로 고려해야 할 것이다.

Keywords

References

  1. Pullarkat V, Bass RD, Gong JZ, Feinstein DI, Brynes RK. Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome. Am J Hematol 2003;72:8-12. https://doi.org/10.1002/ajh.10258
  2. Park SH, Seo YH, Park PH, et al. A case of primary autoimmune myelofibrosis. Korean J Hematol 2009;44:157-162. https://doi.org/10.5045/kjh.2009.44.3.157
  3. Rizzi R, Pastore D, Liso A, et al. Autoimmune myelofibrosis: report of three cases and review of the literature. Leuk Lymphoma 2004;45:561-566. https://doi.org/10.1080/10428190310001597982
  4. Bass RD, Pullarkat V, Feinstein DI, Kaul A, Winberg CD, Brynes RK. Pathology of autoimmune myelofibrosis: a report of three cases and a review of the literature. Am J Clin Pathol 2001;116:211-216. https://doi.org/10.1309/6Q99-VRNL-7BTP-W1G8
  5. Santos FP, Konoplev SN, Lu H, Verstovsek S. Primary autoimmune myelofibrosis in a 36-year-old patient presenting with isolated extreme anemia. Leuk Res 2010;34:e35-37. https://doi.org/10.1016/j.leukres.2009.08.026
  6. Paquette RL, Meshkinpour A, Rosen PJ. Autoimmune myelofibrosis: a steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus. Medicine (Baltimore) 1994;73:145-152. https://doi.org/10.1097/00005792-199405000-00003
  7. Nakao T, Fukushima T, Shimizu T, et al. Transient myelofibrosis with autoimmune pancytopenia: a case report. Eur J Pediatr 2009;168:1003-1006. https://doi.org/10.1007/s00431-008-0867-y
  8. Nichols B, Saadat P, Vadmal MS. Fatal systemic nonuremic calciphylaxis in a patient with primary autoimmune myelofibrosis. Int J Dermatol 2011;50:870-874. https://doi.org/10.1111/j.1365-4632.2010.04595.x
  9. Barbui T, Thiele J, Carobbio A, et al. Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis. Blood 2012;120:569-571. https://doi.org/10.1182/blood-2012-01-407981
  10. Thiele J, Kvasnicka HM, Zerhusen G, et al. Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up. Ann Hematol 2004;83:513-521.
  11. Petri M, Orbai AM, Alarcon GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677-2686. https://doi.org/10.1002/art.34473